+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pharmaceutical Services Outsourcing"

From
Unit Dose Manufacturing Global Market Report 2024 - Product Thumbnail Image

Unit Dose Manufacturing Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
  • 19 Results (Page 1 of 1)
Loading Indicator

Pharmaceutical Services Outsourcing (PSO) is a rapidly growing market within the pharmaceutical manufacturing industry. It involves the transfer of certain activities, such as drug development, clinical trials, and manufacturing, from pharmaceutical companies to third-party service providers. This allows pharmaceutical companies to focus on their core competencies while outsourcing non-core activities to specialized service providers. PSO also helps pharmaceutical companies reduce costs, increase efficiency, and improve quality. The PSO market is segmented into drug development, clinical trials, and manufacturing services. Drug development services include pre-clinical and clinical research, regulatory affairs, and drug safety. Clinical trials services include clinical trial management, data management, and biostatistics. Manufacturing services include active pharmaceutical ingredient (API) manufacturing, finished dosage form (FDF) manufacturing, and packaging and labeling. Notable companies in the PSO market include Parexel, Quintiles, Covance, PRA Health Sciences, and Charles River Laboratories. Show Less Read more